MGRO Stock Overview
An agricultural biotechnology company, focuses on development and commercialization of natural biological technologies and products from mustard seeds. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
+ 1 more risk
My Notes
Capture your thoughts, links and company narrative
MustGrow Biologics Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$1.54 |
| 52 Week High | CA$2.53 |
| 52 Week Low | CA$0.62 |
| Beta | 1.45 |
| 1 Month Change | 4.76% |
| 3 Month Change | 18.46% |
| 1 Year Change | 10.00% |
| 3 Year Change | -57.81% |
| 5 Year Change | 220.83% |
| Change since IPO | 381.25% |
Recent News & Updates
Recent updates
Shareholder Returns
| MGRO | CA Chemicals | CA Market | |
|---|---|---|---|
| 7D | -9.4% | 1.9% | -1.3% |
| 1Y | 10.0% | 3.5% | 15.5% |
Return vs Industry: MGRO exceeded the Canadian Chemicals industry which returned 0.3% over the past year.
Return vs Market: MGRO underperformed the Canadian Market which returned 17.1% over the past year.
Price Volatility
| MGRO volatility | |
|---|---|
| MGRO Average Weekly Movement | 16.9% |
| Chemicals Industry Average Movement | 5.3% |
| Market Average Movement | 8.3% |
| 10% most volatile stocks in CA Market | 18.2% |
| 10% least volatile stocks in CA Market | 2.9% |
Stable Share Price: MGRO's share price has been volatile over the past 3 months compared to the Canadian market.
Volatility Over Time: MGRO's weekly volatility has increased from 12% to 17% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2014 | n/a | Corey Giasson | mustgrow.ca |
MustGrow Biologics Corp., an agricultural biotechnology company, focuses on development and commercialization of natural biological technologies and products from mustard seeds. It provides Biocontrol technology platform to treat soil-borne diseases and pests for various crops, including fruit, vegetables, and others; treat unwanted plant growth for use in organic agriculture, and home and garden markets, as well as agriculture markets where glyphosate has been banned; and suppress sprouting, and treat disease and pathogen for storage and food preservation markets. The company also offers TerraMG, a mustard-derived soil biopesticide technology.
MustGrow Biologics Corp. Fundamentals Summary
| MGRO fundamental statistics | |
|---|---|
| Market cap | CA$81.08m |
| Earnings (TTM) | -CA$245.03k |
| Revenue (TTM) | CA$4.99m |
15.9x
P/S Ratio-324.6x
P/E RatioIs MGRO overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MGRO income statement (TTM) | |
|---|---|
| Revenue | CA$4.99m |
| Cost of Revenue | CA$255.69k |
| Gross Profit | CA$4.74m |
| Other Expenses | CA$4.98m |
| Earnings | -CA$245.03k |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0047 |
| Gross Margin | 94.88% |
| Net Profit Margin | -4.91% |
| Debt/Equity Ratio | 15.4% |
How did MGRO perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/10 23:06 |
| End of Day Share Price | 2025/01/10 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
MustGrow Biologics Corp. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Joseph Gomes | NOBLE Capital Markets, Inc. |